Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared on LinkedIn:
”Thalassemia is a rare blood disorder that still affects about 7,000 patients in Italy, many of whom depend on lifelong transfusions.
Research has changed the course of this disease in recent decades, but much remains to be done to prevent complications and move closer to a cure.
At the Franco and Piera Cutino Foundation we work every day on research, prevention and innovative therapies, from early prenatal diagnosis to gene therapy and international collaboration on rare hematologic diseases.
In this video I share the mission and the projects we are advancing, also supported by our Easter solidarity campaign ‘Giving makes you happy’.”
Stay updated with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe